Balansräkning Novo Nordisk A/S

Aktier

NOVO B

DK0062498333

Farmaceutiska produkter

Realtidsuppskattning Cboe Europe Andra börsplatser 16.11.29 2025-12-15			5-dagars förändring	Förändring 1 jan.
315,28 ^DKK	−1,83 %		+6,25 %	−49,10 %

12.54	Eli Lilly kan få FDA:s beslut om viktminskningspillret Orforglipron senast i mars 2026	MT
10.58	Kepler upprepar köp för Novo Nordisk - främsta sektorvalet	FW

e40f0d9f9a6936a7208ed.9FPWjAYJE7v5CcpmI6N1Ov5BNVsETc7lTQuEsijRjzs.vD233E5ldsirZ4A0WdVMfbIgAiNVdJyOem3Uw3m7_W3NZrz4UV9568tMhw

Publicerade finansiella data: NOVO NORDISK A/S

Årlig

Kvartalsvis

Halvårsvis

YTD

LTM

Skatteperiod: December	2020	2021	2022	2023	2024
Revenues	127 md	141 md	177 md	232 md	290 md
Total Revenues	127 md	141 md	177 md	232 md	290 md
Cost of Goods Sold, Total	20,93 md	23,66 md	28,45 md	35,76 md	43,56 md
Gross Profit	106 md	117 md	149 md	196 md	247 md
Selling General & Admin Expenses, Total	36,89 md	41,06 md	50,68 md	61,6 md	67,37 md
R&D Expenses	15,11 md	17,2 md	23,29 md	31,03 md	40,07 md
Other Operating Expenses	−460 mn	−456 mn	−1,08 md	−119 mn	−476 mn
Other Operating Expenses, Total	51,54 md	57,8 md	72,89 md	92,51 md	107 md
Operating Income	54,48 md	59,34 md	75,62 md	104 md	140 md
Interest Expense, Total	−390 mn	−289 mn	−378 mn	−542 mn	−1,64 md
Interest And Investment Income	337 mn	231 mn	239 mn	1,07 md	1,84 md
Net Interest Expenses	−53 mn	−58 mn	−139 mn	527 mn	198 mn
Income (Loss) On Equity Invest.	149 mn	−24 mn	−189 mn	81 mn	−17 mn
Currency Exchange Gains (Loss)	−747 mn	344 mn	−4,65 md	1,65 md	−1,02 md
Other Non Operating Income (Expenses)	−150 mn	−122 mn	−181 mn	−197 mn	−289 mn
EBT, Excl. Unusual Items	53,68 md	59,48 md	70,46 md	106 md	139 md
Merger & Related Restructuring Charges	-	−124 mn	−51 mn	-	−978 mn
Gain (Loss) On Sale Of Investments	−195 mn	296 mn	−587 mn	37 mn	−17 mn
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	−350 mn	−573 mn	−760 mn	−1,41 md	−10,56 md
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	53,13 md	59,08 md	69,06 md	105 md	127 md
Income Tax Expense	10,99 md	11,32 md	13,54 md	20,99 md	26,2 md
Earnings From Continuing Operations	42,14 md	47,76 md	55,52 md	83,68 md	101 md
Net Income to Company	42,14 md	47,76 md	55,52 md	83,68 md	101 md
Net Income - (IS)	42,14 md	47,76 md	55,52 md	83,68 md	101 md
Net Income to Common Incl Extra Items	42,14 md	47,76 md	55,52 md	83,68 md	101 md
Net Income to Common Excl. Extra Items	42,14 md	47,76 md	55,52 md	83,68 md	101 md
Per aktie poster
Net EPS - Basic	9,03	10,4	12,26	18,67	22,67
Basic EPS - Continuing Operations	9,03	10,4	12,26	18,67	22,67
Basic Weighted Average Shares Outstanding	4,67 md	4,59 md	4,53 md	4,48 md	4,45 md
Net EPS - Diluted	9	10,37	12,22	18,62	22,63
Diluted EPS - Continuing Operations	9	10,37	12,22	18,62	22,63
Diluted Weighted Average Shares Outstanding	4,68 md	4,61 md	4,54 md	4,49 md	4,46 md
Normalized Basic EPS	7,19	8,09	9,72	14,79	19,47
Normalized Diluted EPS	7,17	8,07	9,69	14,75	19,43
Dividend Per Share	4,55	5,2	6,2	9,4	11,4
Payout Ratio	47,75	45,06	45,57	37,96	43,71
American Depositary Receipts Ratio (ADR)	0	0	0	0	0
Kompletterande punkter
EBITDA	58,79 md	63,55 md	80,93 md	110 md	147 md
EBITA	55,57 md	60,21 md	77,02 md	106 md	142 md
EBIT	54,48 md	59,34 md	75,62 md	104 md	140 md
EBITDAR	59,1 md	64,86 md	82,42 md	112 md	-
Effective Tax Rate - (Ratio)	20,69	19,17	19,6	20,05	20,6
Total Current Taxes	10,99 md	13,27 md	18,17 md	25 md	32,25 md
Total Deferred Taxes	−2 mn	−1,94 md	−4,63 md	−4,01 md	−6,05 md
Normalized Net Income	33,55 md	37,18 md	44,04 md	66,28 md	86,72 md
Interest on Long-Term Debt	97 mn	-	-	-	-
Non-Cash Pension Expense	138 mn	139 mn	185 mn	126 mn	156 mn
Kompletterande driftskostnadsposter
Selling and Marketing Expenses	32,93 md	37,01 md	46,22 md	56,74 md	62,09 md
General and Administrative Expenses	3,96 md	4,05 md	4,47 md	4,86 md	5,28 md
Research And Development Expense From Footnotes	15,46 md	17,77 md	24,05 md	32,44 md	48,06 md
Net Rental Expense, Total	312 mn	1,3 md	1,49 md	1,83 md	-
Imputed Operating Lease Interest Expense	131 mn	163 mn	172 mn	301 mn	-
Imputed Operating Lease Depreciation	181 mn	1,14 md	1,32 md	1,53 md	-
Stock-Based Comp., Other (Total)	823 mn	1,04 md	1,54 md	2,15 md	2,29 md
Total Stock-Based Compensation	823 mn	1,04 md	1,54 md	2,15 md	2,29 md

Skatteperiod: December	2020	2021	2022	2023	2024
TILLGÅNGAR
Cash And Equivalents	12,76 md	10,72 md	12,65 md	14,39 md	15,66 md
Short Term Investments	-	6,76 md	10,92 md	15,84 md	10,65 md
Total Cash And Short Term Investments	12,76 md	17,48 md	23,57 md	30,23 md	26,31 md
Accounts Receivable, Total	27,73 md	40,64 md	50,56 md	64,77 md	71,95 md
Other Receivables	4,45 md	6,16 md	6,94 md	10,49 md	15,46 md
Total Receivables	32,18 md	46,8 md	57,5 md	75,26 md	87,41 md
Inventory	18,54 md	19,62 md	24,39 md	31,81 md	40,85 md
Other Current Assets, Total	2,33 md	1,69 md	2,73 md	2,34 md	6,33 md
Total Current Assets	65,81 md	85,6 md	108 md	140 md	161 md
Gross Property Plant And Equipment	86,69 md	95,89 md	111 md	139 md	215 md
Accumulated Depreciation	−36,42 md	−40,52 md	−44,76 md	−47,62 md	−52,4 md
Net Property Plant And Equipment	50,27 md	55,36 md	66,67 md	90,96 md	162 md
Long-term Investments	1,65 md	1,44 md	1,34 md	1,66 md	2,68 md
Goodwill	-	4,35 md	5,09 md	4,46 md	20,06 md
Other Intangibles, Total	20,66 md	38,82 md	46,32 md	55,94 md	91,03 md
Deferred Tax Assets Long-Term	5,86 md	8,67 md	13,43 md	20,38 md	24,63 md
Other Long-Term Assets, Total	674 mn	267 mn	206 mn	1,43 md	4,02 md
Total Assets	145 md	195 md	241 md	314 md	466 md
Skulder
Accounts Payable, Total	5,72 md	8,87 md	15,59 md	25,61 md	28,85 md
Accrued Expenses, Total	33,75 md	50,57 md	69,18 md	100 md	119 md
Short-term Borrowings	6,68 md	12,86 md	480 mn	456 mn	5,79 md
Current Portion of Long-Term Debt	-	-	-	4,85 md	5,98 md
Current Portion of Leases	775 mn	822 mn	986 mn	1,17 md	1,34 md
Current Income Taxes Payable	3,91 md	3,66 md	7,09 md	7,12 md	9,72 md
Other Current Liabilities	19,43 md	22,74 md	27,62 md	30,43 md	46,92 md
Total Current Liabilities	70,27 md	99,52 md	121 md	170 md	218 md
Long-Term Debt	-	9,65 md	20,78 md	15,98 md	84,25 md
Long-Term Leases	2,9 md	3,31 md	3,54 md	4,55 md	5,43 md
Pension & Other Post Retirement Benefits	1,4 md	1,28 md	762 mn	742 mn	903 mn
Deferred Tax Liability Non Current	2,5 md	5,27 md	7,06 md	10,16 md	5,43 md
Other Non Current Liabilities	4,53 md	4,73 md	4,69 md	6,84 md	8,78 md
Total Liabilities	81,6 md	124 md	158 md	208 md	322 md
Common Stock, Total	470 mn	462 mn	456 mn	451 mn	446 mn
Retained Earnings	63,77 md	72 md	80,59 md	105 md	144 md
Treasury Stock	−8 mn	−6 mn	−6 mn	−5 mn	−2 mn
Comprehensive Income and Other	−911 mn	−1,71 md	2,45 md	1,28 md	−1,41 md
Total Common Equity	63,32 md	70,75 md	83,49 md	107 md	143 md
Total Equity	63,32 md	70,75 md	83,49 md	107 md	143 md
Total Liabilities And Equity	145 md	195 md	241 md	314 md	466 md
Kompletterande objekt
ECS Total Shares Outstanding on Filing Date	4,62 md	4,56 md	4,5 md	4,46 md	4,44 md
ECS Total Common Shares Outstanding	4,62 md	4,56 md	4,5 md	4,46 md	4,44 md
Book Value / Share	13,69	15,52	18,55	23,9	32,31
Tangible Book Value	42,67 md	27,58 md	32,07 md	46,16 md	32,4 md
Tangible Book Value Per Share	9,23	6,05	7,13	10,35	7,29
Total Debt	10,36 md	26,64 md	25,78 md	27,01 md	103 md
Net Debt	−2,4 md	9,16 md	2,21 md	−3,22 md	76,48 md
Debt Equivalent of Unfunded Proj. Benefit Obligation	1,4 md	-	-	-	-
Debt Equivalent Oper. Leases	2,5 md	10,42 md	11,93 md	14,66 md	-
Equity Method Investments, Total	582 mn	525 mn	327 mn	410 mn	400 mn
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	3,33 md	4,31 md	6,39 md	9,5 md	13,37 md
Inventories - Work In Process, Total	12,25 md	12,28 md	13,67 md	17,6 md	22,34 md
Inventories - Finished Goods, Total	5,11 md	5,28 md	6,04 md	7,22 md	8,87 md
Land - (BS)	37,51 md	41,08 md	43,4 md	48,99 md	62,14 md
Machinery, Total	38,38 md	43,72 md	45,66 md	49,93 md	73,36 md
Full Time Employees	44,72 tn	47,79 tn	54,39 tn	63,37 tn	76,3 tn
Part Time Employees	600	686	792	949	1,05 tn
Accumulated Allowance for Doubtful Accounts (Supple)	1,38 md	1,43 md	1,52 md	1,79 md	2,13 md

Skatteperiod: December	2020	2021	2022	2023	2024
Net Income	42,14 md	47,76 md	55,52 md	83,68 md	101 md
Depreciation & Amortization - CF	4,18 md	4,24 md	4,95 md	5,46 md	6,03 md
Amortization of Goodwill and Intangible Assets - (CF)	1,1 md	866 mn	1,4 md	1,62 md	2,26 md
Depreciation & Amortization, Total	5,28 md	5,11 md	6,36 md	7,08 md	8,29 md
Amortization of Deferred Charges, Total - (CF)	-	200 mn	195 mn	213 mn	255 mn
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	195 mn	−340 mn	124 mn	-	−5,08 md
Asset Writedown & Restructuring Costs	477 mn	714 mn	809 mn	2,12 md	10,56 md
(Income) Loss On Equity Investments - (CF)	−149 mn	24 mn	189 mn	-	17 mn
Stock-Based Compensation (CF)	823 mn	1,04 md	1,54 md	-	2,29 md
Other Operating Activities, Total	7,54 md	9,15 md	19,48 md	28,06 md	15,64 md
Change In Accounts Receivable	−2,82 md	−12,91 md	−9,92 md	−14,21 md	−7,18 md
Change In Inventories	−895 mn	−1,08 md	−4,77 md	−7,42 md	−9,04 md
Change In Accounts Payable	−641 mn	3,15 md	6,72 md	10,02 md	3,24 md
Change in Other Net Operating Assets	5 mn	2,18 md	2,63 md	−631 mn	982 mn
Cash from Operations	51,95 md	55 md	78,89 md	109 md	121 md
Capital Expenditure	−5,82 md	−6,34 md	−12,15 md	−25,81 md	−47,16 md
Sale of Property, Plant, and Equipment	7 mn	-	-	-	-
Cash Acquisitions	-	−18,28 md	−7,08 md	-	−82,16 md
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	−16,26 md	−1,05 md	−2,61 md	−13,09 md	−4,14 md
Investment in Marketable and Equity Securities, Total	−380 mn	−5,94 md	−3,09 md	−5 md	4,58 md
Other Investing Activities, Total	18 mn	4 mn	-	-	-
Cash from Investing	−22,44 md	−31,6 md	−24,92 md	−43,89 md	−129 md
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	5,68 md	22,16 md	11,22 md	-	79,39 md
Total Debt Issued	5,68 md	22,16 md	11,22 md	-	79,39 md
Long-Term Debt Repaid, Total	−950 mn	−6,69 md	−13,62 md	−1,47 md	−6,34 md
Total Debt Repaid	−950 mn	−6,69 md	−13,62 md	−1,47 md	−6,34 md
Repurchase of Common Stock	−16,86 md	−19,45 md	−24,09 md	−29,92 md	−20,18 md
Common Dividends Paid	−20,12 md	−21,52 md	−25,3 md	−31,77 md	−44,14 md
Common & Preferred Stock Dividends Paid	−20,12 md	−21,52 md	−25,3 md	−31,77 md	−44,14 md
Cash from Financing	−32,24 md	−25,49 md	−51,8 md	−63,16 md	8,74 md
Foreign Exchange Rate Adjustments	−456 mn	591 mn	−238 mn	−119 mn	455 mn
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	−3,18 md	−1,51 md	1,93 md	1,74 md	1,26 md
Kompletterande punkter
Cash Interest Paid	422 mn	261 mn	272 mn	491 mn	612 mn
Cash Income Tax Paid (Refund)	10,11 md	14,44 md	14,52 md	25,9 md	29,64 md
Levered Free Cash Flow	17,06 md	43,83 md	57,5 md	54,1 md	61,99 md
Unlevered Free Cash Flow	17,3 md	44,01 md	57,73 md	54,44 md	63,01 md
Change In Net Working Capital	766 mn	−7,96 md	−17,13 md	−18,91 md	−16,06 md
Net Debt Issued / Repaid	4,73 md	15,47 md	−2,41 md	−1,47 md	73,06 md

Skatteperiod: December	2020	2021	2022	2023	2024
Lönsamhet
Return on Assets	25,17	21,85	21,69	23,39	22,41
Return on Total Capital	50,16	43,36	45,74	53,53	46,03
Return On Equity %	69,7	71,24	72	88,07	80,78
Return on Common Equity	69,7	71,24	72	88,07	80,78
Marginalanalys
Gross Profit Margin %	83,51	83,2	83,92	84,6	85
SG&A Margin	29,06	29,16	28,64	26,52	23,2
EBITDA Margin %	46,31	45,14	45,73	47,28	50,51
EBITA Margin %	43,78	42,76	43,53	45,47	48,94
EBIT Margin %	42,91	42,15	42,73	44,77	48,17
Income From Continuing Operations Margin %	33,19	33,92	31,38	36,03	34,78
Net Income Margin %	33,19	33,92	31,38	36,03	34,78
Net Avail. For Common Margin %	33,19	33,92	31,38	36,03	34,78
Normalized Net Income Margin	26,43	26,4	24,89	28,54	29,86
Levered Free Cash Flow Margin	13,44	31,13	32,49	23,29	21,35
Unlevered Free Cash Flow Margin	13,63	31,26	32,63	23,44	21,7
Tillgångsomslutning
Asset Turnover	0,94	0,83	0,81	0,84	0,74
Fixed Assets Turnover	2,52	2,67	2,9	2,95	2,29
Receivables Turnover (Average Receivables)	4,82	4,12	3,88	4,03	4,25
Inventory Turnover (Average Inventory)	1,16	1,24	1,29	1,27	1,2
Kortfristig likviditet
Current Ratio	0,94	0,86	0,89	0,82	0,74
Quick Ratio	0,64	0,65	0,67	0,62	0,52
Operating Cash Flow to Current Liabilities	0,74	0,55	0,65	0,64	0,56
Days Sales Outstanding (Average Receivables)	75,89	88,63	94,06	90,62	86,15
Days Outstanding Inventory (Average Inventory)	316,28	294,35	282,33	286,77	305,25
Average Days Payable Outstanding	101,24	107,59	134,38	174,07	189,45
Cash Conversion Cycle (Average Days)	290,93	275,38	242,01	203,32	201,96
Långsiktig solvens
Total Debt/Equity	16,35	37,66	30,88	25,34	71,64
Total Debt / Total Capital	14,06	27,36	23,6	20,22	41,74
LT Debt/Equity	4,57	18,32	29,13	19,26	62,5
Long-Term Debt / Total Capital	3,93	13,31	22,25	15,37	36,41
Total Liabilities / Total Assets	56,3	63,63	65,4	66,12	69,2
EBIT / Interest Expense	139,68	205,33	200,05	191,86	85,29
EBITDA / Interest Expense	153,21	223,02	216,87	204,92	90,35
(EBITDA - Capex) / Interest Expense	138,27	201,1	184,74	157,3	61,59
Total Debt / EBITDA	0,17	0,41	0,31	0,24	0,69
Net Debt / EBITDA	−0,04	0,14	0,03	−0,03	0,52
Total Debt / (EBITDA - Capex)	0,19	0,46	0,37	0,32	1,02
Net Debt / (EBITDA - Capex)	−0,04	0,16	0,03	−0,04	0,76
Tillväxt jämfört med föregående år
Total Revenues, 1 Yr. Growth %	4,04	10,91	25,68	31,26	25,03
Gross Profit, 1 Yr. Growth %	3,47	10,5	26,77	32,32	25,34
EBITDA, 1 Yr. Growth %	3,01	8,49	27,34	35,78	32,7
EBITA, 1 Yr. Growth %	3,01	8,75	27,93	37,2	33,69
EBIT, 1 Yr. Growth %	1,9	8,93	27,43	37,61	33,6
Earnings From Cont. Operations, 1 Yr. Growth %	8,18	13,33	16,27	50,71	20,68
Net Income, 1 Yr. Growth %	8,18	13,33	16,27	50,71	20,68
Normalized Net Income, 1 Yr. Growth %	8,05	10,82	18,46	50,62	29,96
Diluted EPS Before Extra, 1 Yr. Growth %	9,95	15,16	17,84	52,37	21,54
Accounts Receivable, 1 Yr. Growth %	11,33	46,55	24,4	28,11	11,08
Inventory, 1 Yr. Growth %	5,07	5,85	24,3	30,44	28,41
Net Property, Plant and Equip., 1 Yr. Growth %	−0,56	10,13	20,43	36,43	78,63
Total Assets, 1 Yr. Growth %	15,37	34,22	24,03	30,35	48,11
Tangible Book Value, 1 Yr. Growth %	−17,56	−35,37	16,3	41,81	−29,81
Common Equity, 1 Yr. Growth %	9,95	11,72	18,01	27,64	34,65
Cash From Operations, 1 Yr. Growth %	11,05	5,87	43,43	38,06	11,07
Capital Expenditures, 1 Yr. Growth %	−34,79	8,76	91,73	112,46	82,76
Levered Free Cash Flow, 1 Yr. Growth %	−37,24	157	31,17	−5,85	13,64
Unlevered Free Cash Flow, 1 Yr. Growth %	−36,66	154,42	31,17	−5,65	14,81
Dividend Per Share, 1 Yr. Growth %	8,98	14,29	19,23	51,61	21,28
Sammansatt Årlig Tillväxthastighet Över Två År
Total Revenues, 2 Yr. CAGR %	6,54	7,42	18,06	28,44	28,11
Gross Profit, 2 Yr. CAGR %	6,08	7,2	18,36	29,52	28,91
EBITDA, 2 Yr. CAGR %	7,18	6,24	17,55	31,23	34,46
EBITA, 2 Yr. CAGR %	8,45	6,61	18,1	32,36	35,67
EBIT, 2 Yr. CAGR %	7,38	6,33	18,2	32,52	36,01
Earnings From Cont. Operations, 2 Yr. CAGR %	4,44	10,73	14,79	32,37	34,86
Net Income, 2 Yr. CAGR %	4,44	10,73	14,79	32,37	34,86
Normalized Net Income, 2 Yr. CAGR %	6,36	10,52	14,95	33,67	40,33
Diluted EPS Before Extra, 2 Yr. CAGR %	6,33	12,52	16,49	34	36,08
Accounts Receivable, 2 Yr. CAGR %	10,32	27,73	35,02	26,24	19,29
Inventory, 2 Yr. CAGR %	6,52	5,46	14,7	27,33	29,42
Net Property, Plant and Equip., 2 Yr. CAGR %	9,54	4,65	15,16	28,18	56,11
Total Assets, 2 Yr. CAGR %	14,38	24,44	29,02	27,15	38,95
Tangible Book Value, 2 Yr. CAGR %	−4,41	−27,01	−13,3	29,38	−0,23
Common Equity, 2 Yr. CAGR %	10,52	10,83	14,82	22,73	31,1
Cash From Operations, 2 Yr. CAGR %	7,91	8,43	23,23	40,72	23,83
Capital Expenditures, 2 Yr. CAGR %	−22,25	−15,78	44,4	101,83	97,06
Levered Free Cash Flow, 2 Yr. CAGR %	−21,24	27,93	84,1	11,02	3,83
Unlevered Free Cash Flow, 2 Yr. CAGR %	−20,75	27,86	83,17	11,14	4,47
Dividend Per Share, 2 Yr. CAGR %	5,67	11,6	16,73	34,45	35,6
Treårig Sammansatt Årlig Tillväxthastighet
Total Revenues, 3 Yr. CAGR %	4,36	7,98	13,19	22,31	27,29
Gross Profit, 3 Yr. CAGR %	4,07	7,53	13,36	22,84	28,2
EBITDA, 3 Yr. CAGR %	4,08	7,49	12,85	23,31	32
EBITA, 3 Yr. CAGR %	4,31	8,41	13,29	24,13	33,1
EBIT, 3 Yr. CAGR %	3,62	7,89	12,95	24,32	33,18
Earnings From Cont. Operations, 3 Yr. CAGR %	3,39	7,33	12,54	25,7	28,35
Net Income, 3 Yr. CAGR %	3,39	7,33	12,54	25,7	28,35
Normalized Net Income, 3 Yr. CAGR %	3,29	7,82	13,1	25,76	32,71
Diluted EPS Before Extra, 3 Yr. CAGR %	5,38	9,19	14,27	27,4	29,71
Accounts Receivable, 3 Yr. CAGR %	11,21	21,28	26,61	32,67	20,97
Inventory, 3 Yr. CAGR %	6,44	6,3	11,4	19,73	27,69
Net Property, Plant and Equip., 3 Yr. CAGR %	12,56	9,74	9,67	21,86	43,18
Total Assets, 3 Yr. CAGR %	12,29	20,64	24,3	29,47	33,79
Tangible Book Value, 3 Yr. CAGR %	−2,82	−16,1	−14,75	2,65	5,52
Common Equity, 3 Yr. CAGR %	8,33	10,92	13,17	18,94	26,58
Cash From Operations, 3 Yr. CAGR %	8,06	7,22	19,03	27,98	30,05
Capital Expenditures, 3 Yr. CAGR %	−8,59	−13,05	10,79	64,24	95,26
Levered Free Cash Flow, 3 Yr. CAGR %	−7,24	16,82	29	47,2	12,19
Unlevered Free Cash Flow, 3 Yr. CAGR %	−6,88	16,91	28,96	46,8	12,65
Dividend Per Share, 3 Yr. CAGR %	5,05	8,47	14,09	27,36	29,91
Sammansatt Årlig Tillväxthastighet Över Fem År
Total Revenues, 5 Yr. CAGR %	3,3	4,72	9,64	15,74	18,94
Gross Profit, 5 Yr. CAGR %	2,93	4,37	9,56	15,84	19,35
EBITDA, 5 Yr. CAGR %	3,47	4,24	9,19	16,5	21,1
EBITA, 5 Yr. CAGR %	3,58	4,27	9,48	17,45	21,82
EBIT, 5 Yr. CAGR %	3,16	4,15	9,08	17,09	21,66
Earnings From Cont. Operations, 5 Yr. CAGR %	3,86	4,72	7,81	16,72	20,99
Net Income, 5 Yr. CAGR %	3,86	4,72	7,81	16,72	20,99
Normalized Net Income, 5 Yr. CAGR %	5,72	4,48	7,66	17,45	23,29
Diluted EPS Before Extra, 5 Yr. CAGR %	5,9	6,75	9,69	18,51	22,54
Accounts Receivable, 5 Yr. CAGR %	12,36	14,97	20,18	23,24	23,63
Inventory, 5 Yr. CAGR %	7,76	6,47	9,67	14,26	18,29
Net Property, Plant and Equip., 5 Yr. CAGR %	14,5	12,9	13,6	16,77	26,3
Total Assets, 5 Yr. CAGR %	9,56	14,8	18,71	23,21	29,97
Tangible Book Value, 5 Yr. CAGR %	−0,98	−8,31	−7,16	−0,23	−8,95
Common Equity, 5 Yr. CAGR %	6,16	9,34	10,88	15,5	20,03
Cash From Operations, 5 Yr. CAGR %	6,29	2,63	13,89	19,54	20,93
Capital Expenditures, 5 Yr. CAGR %	2,2	−2,17	9,76	21,78	39,49
Levered Free Cash Flow, 5 Yr. CAGR %	−9,84	8,96	21,89	14,5	18,27
Unlevered Free Cash Flow, 5 Yr. CAGR %	−9,61	9,02	21,93	14,6	18,54
Dividend Per Share, 5 Yr. CAGR %	7,29	6,47	9,57	18,2	22,25